Meropenem; Vaborbactam Patent Expiration
Meropenem; Vaborbactam is used for complicated urinary tract infections caused by specified susceptible microorganisms in patients 18 years of age and older. It was first introduced by Rempex Pharmaceuticals Inc A Wholly Owned Sub Of Melinta Therapeutics Llc
Meropenem; Vaborbactam Patents
Given below is the list of patents protecting Meropenem; Vaborbactam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vabomere | US11376237 | Methods of treating bacterial infections | Apr 06, 2039 | Rempex |
| Vabomere | US8680136 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Aug 29, 2031 | Rempex |
| Vabomere | US10172874 | Pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Aug 08, 2031 | Rempex |
| Vabomere | US10183034 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Aug 08, 2031 | Rempex |
| Vabomere | US10561675 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Aug 08, 2031 | Rempex |
| Vabomere | US11007206 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Aug 08, 2031 | Rempex |
| Vabomere | US9694025 | Cyclic boronic acid ester derivatives and therapeutic uses thereof | Aug 08, 2031 | Rempex |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Meropenem; Vaborbactam's patents.
Latest Legal Activities on Meropenem; Vaborbactam's Patents
Given below is the list recent legal activities going on the following patents of Meropenem; Vaborbactam.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Mail-Record Petition Decision of Granted to Make Entity Status large | 19 Jul, 2024 | US11007206 |
| Record Petition Decision of Granted to Make Entity Status large | 18 Jul, 2024 | US11007206 |
| Mail O.P. Petition Decision | 30 Jan, 2024 | US9694025 |
| Email Notification Critical | 30 Jan, 2024 | US9694025 |
| Mail-Record Petition Decision of Granted to Make Entity Status large | 26 Jan, 2024 | US9694025 |
| O.P. Petition Decision | 25 Jan, 2024 | US9694025 |
| Record Petition Decision of Granted to Make Entity Status large | 25 Jan, 2024 | US9694025 |
| Payment of Maintenance Fee under 1.28(c) | 05 Jan, 2024 | US9694025 |
| Petition Entered | 05 Jan, 2024 | US9694025 |
| Mail O.P. Petition Decision | 06 Dec, 2023 | US9694025 |
Meropenem; Vaborbactam's Family Patents
